Biote Corp. Warrant
BTMDW
BTMDW was delisted on the 6th of July, 2023.
34 hedge funds and large institutions have $6.56M invested in Biote Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 8 closing their positions.
47% more capital invested
Capital invested by funds: $4.46M → $6.56M (+$2.1M)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 39 → 34 (-5)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$101K |
| 2 |
Walleye Capital
New York
|
+$53.9K |
| 3 |
AR
Advisory Research
Chicago,
Illinois
|
+$9.06K |
| 4 |
Two Sigma Investments
New York
|
+$4.21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.03K |
Top Sellers
BTMDW Hedge Fund Activity: Q1 2023 in Review
34 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biote Corp. Warrant (BTMDW) for Q1 2023, worth a combined $6.56M — up 47% from $4.46M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BTMDW and 4 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Kent Lake Capital, opening a new position worth an estimated $101K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $240K sold.
- 34 institutional investors held Biote Corp. Warrant (BTMDW) as of Q1 2023, down from 39 in Q4 2022.
- Funds reported $6.56M of Biote Corp. Warrant stock for Q1 2023, up 47% quarter-over-quarter.
- 4 funds opened new Biote Corp. Warrant positions in Q1 2023 and 8 closed out, a net change of -4 holders.
- The largest Biote Corp. Warrant buyer in Q1 2023 was Kent Lake Capital, an estimated $101K added.
- The largest Biote Corp. Warrant seller in Q1 2023 was Radcliffe Capital Management, an estimated $240K sold.
Based on aggregated 13F filings for Q1 2023.